Trellus Health Share Discussion Threads

[senttothegallows] 07/9/2022 08:16

This will be snapped up IMHO

[wan] 07/9/2022 08:11

By my estimates, the market cap is still currently worth less than the cash element, even with todays notable share price improvement.

[wan] 31/8/2022 06:30

Over 11m shares traded in Trellus Health yesterday, which was a higher trade volume than in Legal & General!

One would assume that there will be accompanying holding announcements in due course, and perhaps something more. Time will tell.

[faz] 30/8/2022 06:32

At 7p mdown from 70p a passive investor will need a return of 10 times to get back what they invested, just to be flat. Anyone subscribing to the fundraise in May would have lost over 80% of their investment. Like Renalytix there appears to be no business acuman behind the idea and like Renalyix the stock market has been used as a money-raid and for no other reason.

[wan] 27/8/2022 03:22

And I note a larger jump in volume yesterday.

[wan] 24/8/2022 16:11

Notable volume today.

[wan] 13/8/2022 10:26

I also meant to add that EKF indicated their intention to launch a Calprotectin test this year. Fecal calprotectin (or faecal in the UK), is a marker of mucosal inflammation. The test can help physicians diagnose inflammatory bowel diseases, such as Crohn's disease and ulcerative colitis, and differentiate them from irritable bowel syndrome (IBS).

Going forwards, Trellus intend to also address IBS, and I note a test for this is included in the indicated list of tests at EKF owned ADL Health laboratory in the US.

[wan] 13/8/2022 10:06

I note recently that some large players are actively interested or indeed already moving into the area of addressing chronic conditions.

I also note the following -

Congratulations from the entire Trellus community to our co-founder, Dr. Laurie Keefer for receiving the Distinguished Investigator Award for Women in Neurogastroenterology -

Recall that in September 2021 Trellus signed an agreement to provide an Inflammatory Bowel Disease ("IBD") demonstration programme for the Mount Sinai Health System.

Following enrolment, the demonstration programme will coordinate six months of active care management followed by a final programme report, expected to be available within 30 days of programme completion. This initial demonstration programme is expected to commence before the end of 2021 with conclusions from the final programme report expected in 2022.

One would assume that that final programme report must be getting quite close to publication.

[wan] 01/8/2022 06:51

Trellus not intending to sit on their laurels either though with todays announcement.

[wan] 30/7/2022 04:30

I note the large volume yesterday.

[wan] 27/7/2022 09:34

Edit to the above post - In short, it takes time to build up capabilities and develop technology, but it's easier and faster to acquire (or strategically partner with) those who now look attractively affordable. Hence, it's likely we will see M&A activity heat up accordingly going forwards.

[wan] 27/7/2022 09:24

I would also add that the market backdrop has resulted in many valuations being significantly reduced, and will mean that affected companies, especially those such as Trellus with 'scientifically validated' methods delivered by technology, are likely to come on to certain radars.

In Trellus's case, there is the potential from companies looking to pivot, or pivot further, into chronic disease management, either via partnering or acquisition.

In short, it takes time to build up capabilities and develop technology, but it's easier and faster to acquire (or strategically partner with) those who now look attractively affordable. Hence, it's likely we will see M&A activity heat up accordingly going forwards.

[wan] 27/7/2022 08:14

Cambridgedon...As I allude to in post 211, it looks predominantly like a cash burn reduction exercise and a reflection of who can effectively lead Trellus in the current market, and perhaps more passionately lead and effectively deliver on the strategy, given the new CEO is a co-founder and has unrivalled expertise and reputation in Trellus Health's 'initial' market focus.

We may get further clarification in Interim Results ended June 30th 2022.

[cambridgedon] 26/7/2022 15:08

Does anyone know/have a theory as to why Monique Fayad went??
The share price has certainly bombed since the announcement.
CD

[wan] 22/7/2022 08:11

By my estimates, the shares are currently worth considerably less than the cash element i.e. cash is likely to be currently north of £20m and with a market cap under £15m.

And one assumes, due to the recent announcement, that cash burn, which had already been carefully managed, has been further reduced.

Although I am not sure what the prospects offer given those cut backs and indeed the market backdrop etc.

[senttothegallows] 22/7/2022 07:27

24p of shares traded market cap dropped by 5% over £800,000 corruption IMHO

[wan] 19/7/2022 07:52

Still not showing properly within any of my Barclays accounts.

I escalated this shambolic situation to an official complaint with Barclays 'many months' ago, as it also happened with Verici, which are still not registered in my accounts!

I am pushing for 'definitive' answers on exactly why they have been unable to properly register the shares into my accounts.

Chased it again last week, to include Trellus Health, they are still looking into the matters, implying it was complicated in defining who is at fault and why.

[cambridgedon] 18/7/2022 16:49

Thanks adobbing.

[adobbing] 18/7/2022 16:26

Mine showed up around the 24th June, in my ii ISA account

[cambridgedon] 18/7/2022 16:12

A J Bell still not showing my in-specie shares!
Anyone got them showing properly in their portfolios?
CD

[wan] 12/7/2022 07:30

Edit - link to correct article added in the above post

[wan] 12/7/2022 06:57

We're thrilled to announce the official nationwide launch of Trellus Health for all people age 16+ in the US living with Crohn's disease and Ulcerative Colitis -


Trellus Health appear to be in an area that may be somewhat 'differentiated' from the digital health crowd -

Market downturn dampens digital health funding, M&A in 2022. These sectors raked in the most cash
By Heather Landi
Jul 12, 2022

"Venture investors raised record funds last year, meaning they will have capital to deploy for years to come," the researchers wrote. "Meanwhile, startups are using this market moment to reconsider valuations, trim costs, and, in some cases, people, and refine go-to-market strategies. We foresee these startup adjustments activating savvy M&A deal-makers in H2 2022, with pairings between complementary digital health companies likely leading H2 2022 M&A activity."

Digital mental healthcare also continued to be a hot sector, raising a combined $1.3 billion in the first half of 2022 to again reach the top-funded clinical spot, led by Lyra’s $235 million raise in January. However, of that $1.3 billion just $300 million closed in Q2 2022—possibly signaling a slowdown.

Full story -

[wan] 08/7/2022 07:46

The Accidental GastroPsychologist: Building A Business From Behavior Support
07 Jul 2022
INTERVIEWS

Executive Summary
Digital health platforms that offer personalized support are gaining traction in the market, both from patients and investors. Trellus Health is connecting IBD patients with resilience methodologies that enable disease management at lower healthcare costs. Its co-founder Laurie Keefer talks to In Vivo about scaling up the business for greater reach within the market.


You need to sign up for a free trial to get access.

[tommygunn21] 06/7/2022 13:04

It really is but the market is trading irrationally at the minute. These are in bargain territory

[senttothegallows] 06/7/2022 11:03

Valued significantly below cash absolute insanity IMHO